all report title image
  • Published On : Oct 2022
  • Code : CMI5282
  • Industry : Healthcare IT
  • Pages : 243
  • Formats :

Digital biomanufacturing involves the digital technologies to improve the manufacturing process.  It helps to enhanced the biological manufacturing by using computer aided design, verification and manufacture.

The global digital biomanufacturing market is estimated to be valued at US$ 17.92 billion in 2022 and is expected to exhibit a CAGR of 9.9% during the forecast period (2022-2030).

Figure 1. Global Digital Biomanufacturing Market, in Terms of Value (US$ Billion), By Region, 2022

Digital Biomanufacturing  | Coherent Market Insights

Global Digital Biomanufacturing Market: Drivers

Emerging role of digital biomanufacturing is expected to drive the global market growth during the forecast period.

Digital biomanufacturing addresses unique aspects of biological activities and increase the data collection, monitoring, process control algorithms, automation, etc. Advances such as artificial intelligence (AI), automation, and robotics, are changing concepts of manufacturing in general from product development and factory operations to materials supply. Thus, emerging implementation of smart manufacturing in bio-based industries is likely boost the market growth in near future.

CMI table icon

Digital Biomanufacturing Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 17.92 Bn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 9.9% 2030 Value Projection: US$ 38.14 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Manufacturing Technologies, Analytical and Process Control Technologies, Others
  • By Application: Bioprocess Optimization, Biomanufacturing Process Automation and Control, Others
Companies covered:

3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences

Growth Drivers:
  • Emerging role of digital biomanufacturing
  • Expansion of digital biomanufacturing plants
Restraints & Challenges:
  • Lack of awareness regarding the technologically advanced services 

Figure 2. Global Digital Biomanufacturing Market Share (%), By Type, 2022

Digital Biomanufacturing  | Coherent Market Insights

Expansion of digital biomanufacturing plants is expected to drive the global market growth over the forecast period

Key players are increasing their focus on expand the manufacturing process with innovative technologies to improve production process with research and development, paving the way for improved commercialization of important new medicines for patients . This in turn to drive the growth of market. For instance, in October 2019, Sanofi, a global biopharmaceutical company opened its first digitally enabled continuous manufacturing facility in Framingham, Massachusetts.

Global Digital Biomanufacturing Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare sector is one of the sectors, which has been majorly impacted by the pandemic. Thus, surge in adoption of digital technologies in biopharma sector during the pandemic is leads to boosting the demand for digital bioprocessing and thereby drive the growth of market.

Global Digital Biomanufacturing Market: Restraints

Lack of awareness regarding the technologically advanced services in emerging countries are the factors that are likely to hamper the growth of market.

Key Players                   

Major players operating in the global digital biomanufacturing market include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences

Digital biomanufacturing is consider as a potentially greater manifestation of digital biotechnology. Digital biomanufacturing offers real-time process optimization based on extremely valued factors like expected product quality and batch profitability. Digital biomanufacturing software improves asset dependability and availability while lowering maintenance costs. It helps to increase efficiency by elimating the errors.

Advantages of digital manufacturing includes:

  • Increased Monitoring
  • Data Collection and Handling
  • Connectivity
  • Computer power
  • Process control algorithms
  • Automation

Market Dynamics

Digital biomanufacturing helps to improve productivity and robustness of existing processes and facilities. Key issues affecting biomanufacturing facilities can be addressed with the use of new digital technologies. Thus, shift towards smart manufacturing, implementing smart manufacturing is driven the growth of market. Quicker turnaround across all levels of the value chain by digital manufacturing is leads to lowering maintenance costs. This in turn to drive the growth of market. Real-time production visibility made possible by digital technologies offers better information for making important decisions and accelerates innovation. Thus, digital biomanufacturing technology has increasingly use through pharmaceutical and biopharmaceutical industries. Manufacturers are implementing new technologies such as internate of things (IoT),  artificial intelligence (AI) and among others to drive the production is strengthen the demand for digital biomanufacturing. Moreover, automation in manufacturing would provide substantial opportunities to overcome many of the challenges faced in commercial success. This in turn to create significant opportunity for market growth in near future

Key features of the study:

  • This report provides an in-depth analysis of the global digital biomanufacturing market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global digital biomanufacturing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc, GE Healthcare, Culture Biosciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global digital biomanufacturing market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global digital biomanufacturing market

Detailed Segmentation:

  • Global Digital Biomanufacturing Market, By Type:
    • Manufacturing Technologies
    • Analytical and Process Control Technologies
    • Others
  • Global Digital Biomanufacturing Market, By Application:
    • Bioprocess Optimization
    • Biomanufacturing Process Automation and Control
    • Others
  • Global Digital Biomanufacturing Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • 3M*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • ABB
    • Cytiva
    • Siemens
    • immersciobio
    • Sanofi
    • BIOMÉRIEUX
    • Agilent Technologies, Inc
    • GE Healthcare
    • Culture Biosciences

*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global digital biomanufacturing market is estimated to be valued at US$ 17.92 billion in 2022 and is expected to exhibit a CAGR of 9.9% between 2022 and 2030.
Emerging role of digital biomanufacturing and expansion of digital biomanufacturing plants are the factors expected to drive the market growth over the forecast period.
Manufacturing technologies segment is holding a major market share in the market.
The major factor hampering growth of the market include lack of awareness regarding the technologically advanced services.
Major players operating in the market include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc, GE Healthcare, Culture Biosciences

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo